Search Results
Apr 30, 2026, 19:42 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Lufax Holding Ltd. of Class Action Lawsuit and Upcoming Deadlines - LU
Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz
More news about: Pomerantz LLP
Apr 30, 2026, 19:42 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ImmunityBio, Inc. Of Class Action Lawsuit and Upcoming Deadlines - IBRX
Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz
More news about: Pomerantz LLP
Apr 30, 2026, 19:42 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Vital Farms, Inc. Of Class Action Lawsuit and Upcoming Deadlines - VITL
Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz
More news about: Pomerantz LLP
Apr 30, 2026, 19:42 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Coty Inc. Of Class Action Lawsuit and Upcoming Deadlines - COTY
Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz
More news about: Pomerantz LLP
Apr 30, 2026, 19:42 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Stellantis N.V. of Class Action Lawsuit and Upcoming Deadlines - STLA
Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz
More news about: Pomerantz LLP
Apr 30, 2026, 19:42 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Gartner, Inc. of Class Action Lawsuit and Upcoming Deadlines - IT
Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz
More news about: Pomerantz LLP
Apr 30, 2026, 19:42 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Gossamer Bio, Inc. of Class Action Lawsuit and Upcoming Deadlines - GOSS
Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz
More news about: Pomerantz LLP
Apr 30, 2026, 19:42 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in POET Technologies Inc. of Class Action Lawsuit and Upcoming Deadlines - POET
Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz
More news about: Pomerantz LLP
Apr 30, 2026, 19:42 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in SES AI Corporation of Class Action Lawsuit and Upcoming Deadlines - SES
Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz
More news about: Pomerantz LLP
Apr 30, 2026, 19:42 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Super Micro Computer, Inc. Of Class Action Lawsuit and Upcoming Deadlines - SMCI
Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz
More news about: Pomerantz LLP
Apr 30, 2026, 19:42 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Aldeyra Therapeutics, Inc. Of Class Action Lawsuit and Upcoming Deadlines - ALDX
Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz
More news about: Pomerantz LLP
Apr 30, 2026, 19:42 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Power Solutions International, Inc. of Class Action Lawsuit and Upcoming Deadlines - PSIX
Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz
More news about: Pomerantz LLP
Apr 30, 2026, 19:42 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Globant SA of Class Action Lawsuit and Upcoming Deadlines - GLOB
Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz
More news about: Pomerantz LLP
Apr 30, 2026, 19:42 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Concorde International Group, Ltd. of Class Action Lawsuit and Upcoming Deadlines - CIGL
Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz
More news about: Pomerantz LLP
Apr 30, 2026, 19:42 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hercules Capital, Inc. of Class Action Lawsuit and Upcoming Deadlines - HTGC
Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz
More news about: Pomerantz LLP
Apr 30, 2026, 19:42 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Grocery Outlet Holding Corp. of Class Action Lawsuit and Upcoming Deadlines - GO
Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz
More news about: Pomerantz LLP
Apr 30, 2026, 19:42 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in New Era Energy & Digital, Inc. of Class Action Lawsuit and Upcoming Deadlines - NUAI
Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz
More news about: Pomerantz LLP
Apr 30, 2026, 19:02 ET /C O R R E C T I O N -- Amgen/
DeLLphi-303, a Phase 1b study of IMDELLTRA in combination with a programmed cell death protein ligand-1 (PD-L1) inhibitor, carboplatin and etoposide or separately in combination with a PD-L1 inhibitor alone, is ongoing in patients with first-line ES-SCLC.DeLLphi-305, a Phase 3 study of IMDELLTRA
More news about: Amgen
Apr 30, 2026, 17:58 ET Haier Biomedical est à l'origine d'un essor mondial de l'infrastructure des sciences de la vie : les activités internationales atteignent un niveau record, représentant 36 % du chiffre d'affaires annuel en 2025
croissance à deux chiffres dans tous les secteurs d'activité internationaux. Après une décennie d'expansion mondiale, Haier Biomedical est passé de l'« exportation de produits » à la « mondialisation de la marque ». En 2025, le chiffre d'affaires réalisé à l'étranger a affiché une forte croissance composée,
More news about: Haier Biomedical
Apr 30, 2026, 16:30 ET Spire completes sale of gas marketing business to Boardwalk Pipelines for $215 million
better serve customers in a dynamic and increasingly complex energy market. Learn more at bwpipelines.com.Investor Contact:Megan L. [email protected] Media
More news about: Spire Inc.
Apr 30, 2026, 16:30 ET Ted Doheny and Ron Keating Elected to Core Natural Resources' Board of Directors
April 30, 2026 /PRNewswire/ -- Today, Core Natural Resources, Inc. (NYSE: CNR) ("Core," the "company," "we" or "our") announced that Edward L. Doheny II and Ronald C. Keating have been elected to its board of directors at Core's Annual Meeting of Stockholders held on April 30, 2026.
More news about: Core Natural Resources
Apr 30, 2026, 16:20 ET First Industrial Shareholders Re-elect All Company Directors
the Company's incumbent directors – Peter E. Baccile, Teresa Bryce Bazemore, Matthew S. Dominski, H. Patrick Hackett, Jr., Denise A. Olsen and Marcus L. Smith with each obtaining support from more than 93% of the voted shares. As previously announced, Frank E. Schmitz will also be appointed to the Board
More news about: First Industrial Realty Trust, Inc.
Apr 30, 2026, 15:49 ET Wegovy® é mais eficiente em preservar massa muscular durante a perda de peso, mostram novos estudos de vida real
25 mg com uso diário e a injeção semanal de Wegovy® na nova dosagem de 7,2 mg.Referências: Oliveira L. Wegovy pode preservar melhor a massa corporal magra do que Mounjaro, revela estudo; entenda. O Globo. 2026 abr 17. Disponível em:
More news about: Novo Nordisk
Apr 30, 2026, 14:41 ET Former Senior Executive to Curtis "50 Cent" Jackson Files Federal Lawsuit Alleging Years‑Long Campaign of Retaliation, Harassment, and Witness Intimidation
founded by Bennitta L. Joseph and Jon L. Norinsberg. The firm represents employees in workplace discrimination, sexual harassment, whistleblower, wage and hour, and wrongful termination matters across the country, with a focus on New York, New Jersey, and Massachusetts. Bennitta L. Joseph has been named
More news about: Joseph & Norinsberg LLC
Apr 30, 2026, 14:29 ET Norgine annuncia l'autorizzazione all'immissione in commercio da parte della Commissione europea per XOLREMDI ® (mavorixafor), la prima terapia autorizzata per i pazienti con sindrome WHIM nell'Unione Europea
https://rarediseases.org/rare-diseases/whim-syndrome/. Consultato nell'aprile 20263. Badolato R, Alsina L, Azar A, et al. Studio randomizzato di fase 3 su mavorixafor, un antagonista CXCR4, per la sindrome WHIM. Sangue. 2024;144(1):35-454.
More news about: Norgine B.V.